Appili Therapeutics Stock Probability of Future Stock Price Finishing Over 0.0325
| APLI Stock | CAD 0.03 0.01 14.29% |
Appili |
Appili Therapeutics Target Price Odds to finish over 0.0325
The tendency of Appili Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over C$ 0.03 or more in 90 days |
| 0.03 | 90 days | 0.03 | about 71.81 |
Based on a normal probability distribution, the odds of Appili Therapeutics to move over C$ 0.03 or more in 90 days from now is about 71.81 (This Appili Therapeutics probability density function shows the probability of Appili Stock to fall within a particular range of prices over 90 days) . Probability of Appili Therapeutics price to stay between its current price of C$ 0.03 and C$ 0.03 at the end of the 90-day period is about 17.31 .
Assuming the 90 days trading horizon Appili Therapeutics has a beta of -0.77. This suggests as returns on the benchmark increase, returns on holding Appili Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Appili Therapeutics is likely to outperform the market. Additionally Appili Therapeutics has an alpha of 0.6636, implying that it can generate a 0.66 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Appili Therapeutics Price Density |
| Price |
Predictive Modules for Appili Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Appili Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Appili Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Appili Therapeutics is not an exception. The market had few large corrections towards the Appili Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Appili Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Appili Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.66 | |
β | Beta against Dow Jones | -0.77 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.07 |
Appili Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Appili Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Appili Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Appili Therapeutics had very high historical volatility over the last 90 days | |
| Appili Therapeutics has some characteristics of a very speculative penny stock | |
| Appili Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 827.41 K. Net Loss for the year was (3.78 M) with profit before overhead, payroll, taxes, and interest of 1.39 M. | |
| Appili Therapeutics has accumulated about 5.55 M in cash with (2.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Appili Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Appili Stock often depends not only on the future outlook of the current and potential Appili Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Appili Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 121.3 M | |
| Cash And Short Term Investments | 94.5 K |
Appili Therapeutics Technical Analysis
Appili Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Appili Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Appili Therapeutics. In general, you should focus on analyzing Appili Stock price patterns and their correlations with different microeconomic environments and drivers.
Appili Therapeutics Predictive Forecast Models
Appili Therapeutics' time-series forecasting models is one of many Appili Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Appili Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Appili Therapeutics
Checking the ongoing alerts about Appili Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Appili Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Appili Therapeutics had very high historical volatility over the last 90 days | |
| Appili Therapeutics has some characteristics of a very speculative penny stock | |
| Appili Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 827.41 K. Net Loss for the year was (3.78 M) with profit before overhead, payroll, taxes, and interest of 1.39 M. | |
| Appili Therapeutics has accumulated about 5.55 M in cash with (2.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.